VC
United States
Last deal Oct 2026

OrbiMed: €4.6M-€92M checks, Seed to Growth

Check size
€4.6M – €92M
Outreach
Apply via form

Investment focus

Geographic focus

Investment thesis

One of the world's largest healthcare-dedicated investment firms with ~$20B AUM, investing across the full spectrum from seed-stage biotech to large public companies.

How to Pitch OrbiMed

Apply through their form
Source

Recent investments

Auto-extracted from press releases.

Activity trend

Light data · +200%

Last 90d

3

Prior 90d

1

Year ago

0

Portfolio highlights

BioAtla - conditionally active biologics
Nuvalent - precision oncology
ProKidney - regenerative cell therapy

Focus and check size from the firm's website. Website reachable as of Nov 2026.

Ready to reach OrbiMed?

Red-pen your deck first so the gaps are fixed before they read it. A fit check then scores your pitch against their thesis, stage and ticket, and an email draft uses their real deals and thesis, not a template.

Contact

orbimed.com

Reach OrbiMed through the links above. Pitchkit is not affiliated with the firm and does not forward pitches.